The echocardiographic analysis showed that leupeptin treatment greatly suppressed FS increase induced by cardiac overexpression of LRP6 in mice at 4 weeks after TAC (Figure 8C). The gene discussed is LRP6; the disease is persistent truncus arteriosus.